Yüklüyor......
Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban
The new generation of non-vitamin K antagonist oral anticoagulants (NOACs) have been welcomed as a convenient alternative to warfarin. Three new oral anticoagulants, dabigatran etexilate, rivaroxaban and apixaban have been approved for the prevention of stroke and systemic embolism (SSE) in patients...
Kaydedildi:
| Yayımlandı: | Cardiol Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elmer Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5295520/ https://ncbi.nlm.nih.gov/pubmed/28197239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr413w |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|